-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P+77cgBtjpyW06TMf5DTxEyTeSd8g50i4ZpuIAdPvsrOd5UqFxnnD9aVa2dLYgsN 54+lRwYqQdEf4llkVdfQJQ== 0001193125-10-284191.txt : 20101220 0001193125-10-284191.hdr.sgml : 20101220 20101220132836 ACCESSION NUMBER: 0001193125-10-284191 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20101220 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20101220 DATE AS OF CHANGE: 20101220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 101262366 BUSINESS ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 BUSINESS PHONE: 469-893-2701 MAIL ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 20, 2010

 

 

TENET HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Nevada   1-7293   95-2557091

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

1445 Ross Avenue, Suite 1400

Dallas, Texas 75202

(Address of principal executive offices)

Registrant’s telephone number, including area code: (469) 893-2200

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 8.01. Other Events.

On December 20, 2010, Tenet Healthcare Corporation issued a press release, which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The following exhibits are filed herewith:

 

Exhibit
No.
   Description
99.1    Press release issued on December 20, 2010


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on behalf of the undersigned hereunto duly authorized.

Date: December 20, 2010

 

TENET HEALTHCARE CORPORATION
By:  

/s/ Biggs C. Porter

  Name:   Biggs C. Porter
  Title:   Chief Financial Officer


INDEX OF EXHIBITS

 

Exhibit
No.
   Description
99.1    Press release issued on December 20, 2010
EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

LOGO

FOR IMMEDIATE RELEASE

TENET ISSUES STATEMENT REGARDING COMMUNITY HEALTH ANNOUNCEMENT

DALLAS – Dec. 20, 2010 – Tenet Healthcare Corporation (NYSE: THC) today issued the following statement regarding the Community Health Systems, Inc. (NYSE: CYH) announcement that it intends to nominate a slate of director candidates to stand for election at the Company’s 2011 Annual Meeting of Shareholders. The Company has not yet scheduled its 2011 Annual Meeting of Shareholders:

We believe that Community Health intends to nominate candidates for election to the Tenet Board of Directors solely to help advance its inadequate and opportunistic proposal to acquire Tenet. As announced on December 9, 2010, the Tenet Board, after consultation with its financial and legal advisors, unanimously determined that the Community Health proposal to acquire Tenet for $6.00 per share in cash and stock grossly undervalued Tenet and was not in the best interests of Tenet or its shareholders.

Tenet shareholders not Community Health deserve to benefit from Tenet’s growth as we continue to expand margins and benefit from the strategic investments we are making in our business. We are confident that the continued execution of our plan will deliver significantly more value to our shareholders than Community Health’s inadequate proposal.

Tenet has compelling growth prospects and a strong Board of Directors with a broad range of experience. Under the Board’s leadership, Tenet has delivered strong growth for more than five years, demonstrating that our strategy is working. Going forward, we expect significant growth from a combination of acute care revenues, our expanding outpatient business, our business of offering healthcare services to other hospitals, and improved cost efficiencies. As always, we remain focused on executing our core business plan and providing the highest quality care and good value to our customers.

Tenet’s Board is comprised of 10 highly qualified directors, 9 of which are independent, and all of whom are elected annually.

Barclays Capital is acting as financial advisor to Tenet and Gibson, Dunn & Crutcher LLP and Debevoise & Plimpton LLP are acting as Tenet’s legal counsel.

About Tenet Healthcare Corporation

Tenet Healthcare Corporation is a health care services company whose subsidiaries and affiliates own and operate acute care hospitals, ambulatory surgery centers and diagnostic imaging centers. Tenet’s hospitals and related healthcare facilities are committed to providing high quality care to patients in the communities they serve. For more information, please visit www.tenethealth.com.

ADDITIONAL INFORMATION

Tenet Healthcare Corporation (“Tenet”) may file a proxy statement with the SEC. Any definitive proxy statement will be mailed to stockholders of Tenet. INVESTORS AND SECURITYHOLDERS OF TENET ARE URGED TO READ THESE AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and securityholders will be able to obtain free copies of these documents (when available) and other documents filed with the SEC by Tenet through the web site maintained by the SEC at http://www.sec.gov.


CERTAIN INFORMATION REGARDING PARTICIPANTS

Tenet and certain of its respective directors and executive officers may be deemed to be participants under the rules of the SEC. Securityholders may obtain information regarding the names, affiliations and interests of Tenet’s directors and executive officers in Tenet’s proxy statement for the 2010 Annual Meeting, which was filed with the SEC on March 25, 2010. These documents can be obtained free of charge from the sources indicated above. Additional information regarding the interests of these participants in any proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will also be included in any proxy statement and other relevant materials to be filed with the SEC if and when they become available.

Forward Looking Statements

Some of the statements in this release may constitute forward-looking statements. Such forward-looking statements are based on our current expectations and could be affected by numerous factors and are subject to various risks and uncertainties discussed in our filings with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended Dec. 31, 2009, our quarterly reports on Form 10-Q, and periodic reports on Form 8-K. Do not rely on any forward-looking statement, as we cannot predict or control many of the factors that ultimately may affect our ability to achieve the results estimated. We make no promise to update any forward-looking statement, whether as a result of changes in underlying factors, new information, future events or otherwise.

Tenet uses its company web site to provide important information to investors about the company including the posting of important announcements regarding financial performance and corporate developments.

 

Tenet Healthcare Corporation

  
Media:    Investors:
Rick Black (469) 893-2647    Thomas Rice (469) 893-2522
Rick.Black@tenethealth.com    Thomas.Rice@tenethealth.com

Joele Frank / Steve Frankel / Andrew Siegel

  

Joele Frank, Wilkinson Brimmer Katcher

  

(212) 355-4449

  

# # #

 

- 2 -

GRAPHIC 3 g131832ex99_1pg001n.jpg GRAPHIC begin 644 g131832ex99_1pg001n.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`8`"N`P$1``(1`0,1`?_$`-,```$#!`,!```````` M```````("0H!!@<+`@,$!0$``00#`0$```````````````0%!@"D:$0`!`@0$`@<&`@<% M`PT````!`@,`$00%(3$2!D%187&!L2(3!_"1H<'1%3(4X4)2LB,S%O%R0W,U MHK,T8H*2TN)3DZ,D1&2$-O_:``P#`0`"$0,1`#\`G\:((Z%#;'`-@ZA\0W'H M(]``.OIK53B6Q-0.GG&BB\"/+EIC"6<>2G'WC563W#D%FK&F&JX4HF3D\B6^ M$JY7@E[A]J,:RCQ!Y+.3=@@5)LFJH80V`HCIRM]KN-U<";;3NOK`_523+KD) M#ME'%UYJF1YU6L!L9S^'QAA_._U4'B^Q2Y>Q>.I7+_(R39'.FFXQ;C]6(JSA M1/<`$EIR*_J#9=L4RHCHG*&1S?@<7H99*@/[@BJ@?+M8\,R7!V`#O^K5/%.VH**?T4PT[(]&MJ4PE75=0A1R\: M,>>`;'SC1G=M:J?E4Q7SP(EVS[XOZ$^J"\KKQ05S>.RD3S#]+VHG&')-(3)^ MOV72?WD4.X/03$_@TGJ/2G8"&53N:T&6:G&Y#K&D8>Z%*=TW4JDBC5JGA('Z MQG&I_5E9ZJRR7[?_`!?WF(8D#M?R--LMZ@#)&_G'197W&1$`$H=>P[DO]/XZ M8%>C=LK9_:;TPI/#%)^(4!\!"K^J;@C_`(FD6!U$?6'!,%_5<^+_`">Y91&2 MU,T<=IMPH1NO^T&A?B.OM'`C^L!:=QT_M+E)%,?YZ[)`!Z]-,=S]%=VV\%VE M73U5,,E)6-2QSTS/5G"RGW1;W4#STK97R(R[<.Z'U\`@&'FDK*"I60P^AQ0&4P2)]&>/5"CP4*81#K]D_:/V1Z&WVVWV_E M]--LT*R\2NZ%^H?JXQWZWC$&B"#1!!H@@T00:((-$$&B"#1!!H@@T01B7,6< M,5\?<5LUOMD@2,B8QJ03%*G[BHBH[?NE"^VV:H%5=.5 M1`B29CF`H]+;35MT*&:1I3E8LRT)!)'9B<.)RC5YQJG;+CID!$%KR/\`U667 M2\-1,P>($I817]WWAY)+=,0!+/C MWX>TS$;3&F)>:?DSS\:`I<7E[EEG:P&&0F9^R3,G9W$+'O5P0^^+G=;(\&$H M]:15W`5G#ELVVW*B4WZ(W#45^SMHVLN/!NDIVP!I;D%$Y"05JGT@"0VVZ:Y@V,-&[D];ZMU:J>PLM*ILDET'4>1DA2?C(\Q$JH MMFL*QKBO5T2^8([XD88'\+GB\X[-F0X\X9X<>RS5%(GXGR)`?M5LSA4@`(.E MI?(BUE43=<)_:4?T9PN2RRC^6A">H`1=O8&VVYO^$._\ MN^N`0D<_>?K&^/./*\8,Y!`S5^V;OFQPV.W>-T'2!_Z23A-0AOX0UT0MUI6I ME:D*Z#*,X'\0!A,N5.#W#?.+1RSR_P`6L`Y%3=D$BZUJQ-1Y-^.X;=ZIZVI!&0US2.S+WSA&];Z&HF766R3T0TME_ MZ:3QIVZ9_&V#XC+_``ZR8W[E82\<;,K6:L+1+O8IBJ-H>?=V!@@CWD`?::BU M#X%$H>DRI/5/<5(V6;D6*VF4``E]&4N(*"@SYSGAPA"]M^A=`_+A3*DYE!SG MSU3&?$2/3'=2L1^;3@4HBE5LQ8Y\L.`H@I2*43+IFF"^7,3$)=AQ3J>2A4DZ M'=I1%N3M*C.KIG="``51(1WUJ]7[.OZ2X^RNV5JDF2FYEI2^&I)U'/CX>N!* M:^B(0U)QN8SG,#EF/G#I?%SFCC#E*G/0,3!W_$V8Z,T9KY/X]YKJ;VA9BQV= MZJ=NW=2L`\,NPG:R]2ZHG&050J4:=%>968(.7*HS5I>M?U$:Q`"^ZX.4R@^R134NW)ZJ[=H+8NL MH:AI^Z@2T(\4^1F,!U82E.&>V[0KZNH#E8B5,#B21GU9\HV'&)L7K:NC\U-VB>6;'[`4$$DBE%-$ MB:90*'DZMN&X-\7GSY./52U*TM)$Q(`GPCD!B3F98Q:M/34=JIY-Z4M@"9EV M1\\4H;]O/?C5^D(#_E"C@Z_'?[(;CK;^A-XMK\Q5LJP@\FUGY1S-WMLY M%U,^V.S_`%S_`(I]O]/?C7_YAQW]S6R-G[J<,DVZLG_E+^D8^ZVX?XJ?C](R M9A[R=>/OD#D2`Q+A3EUA')N2[3\_^':54;BTE9^8^ZF#B4D18L42]ZP,XYJH MLIM^B0@CKA6[8W#;6#4U]&^S3C-2TE(^,=&[A1/+#;3B5+.0$X6):[M3Z'!2 M%IO%HK]-K$0B9Q+62U2["O0$6@7U6D)B7<-(YFF/P%10N^_33(TV[4/BF80M M;ZL@E)5/JD#"E3B$3*B`!G#;\SYLO$[`3BM=D^>O'E.417,V5*UMYI)BFL13 MVCD-,1C)Y#@!5.@C[_:'Y=2I&QMW.-^:F@?TRGB`#+^Z2%?"$3EUMS2M*W4A M7:>X&%[8FS?AW/%50O&%,GT3*]0<&*FG8\?VB'M<454P=P(+.H9V[(V<=O7V MU.PX!\-1ZKH:V@=#-:TXTZ>"TE/?"QEUJH0'&5!2%9&?M\8^CE'*6.\+T*RY M1RO<(*@XZIL<:7MERL[U.-K]?BP52;F?2K]4/::M@77(03&V#$;.K\ALNK("$YD\(23C;RA^._,5[K&+L6\Q<"7W(=VD0 MB*E3:Q>XR3GK#)F06/_`#">+W*%D:U&D_221VPD%WMI7 MY8=3K/7](<8;/V3U%NY9N47;9VBDX:N6RA7#9RW7("B"[=PD)T5D5B#N4Y3" M4P=0'4;L0V_9/,=XN:?8YZHVCG)Q_@[- M5YN5KEAA)"X$0D(B=@WR\9+QCU`6PBDZCW[51)0/@J:2]343Z MVEIU`A,P0>,-PN=O*RWYJ-:Z-7+M;FA-QU(':>X10?-AXG0`3#SXXZ;!ON/XU3'8`]1'9MZ`'J/H M`:Z?T1N[5I^W5>J4_P"6K+W1HJ]VM!`4\F:I2SX]D.*8\R'2J9+QO98N MY4*\P,;9ZA:X-?YJ'L-?EVY'<9+QCGM*#AD^;'*=,X!L8H@.HT^R]2U+E'4H M6W4M&2DJ!!!Y8\><.2%)6@.(,T'(Q>6N<;1T@40'](XAMT`1+T'<1$=_[7PV MUKI;Y_$_6,:S^QC%/:`1[MS;[[[B!!VZ[[!]D-@]?S]=9(!1H29)Z"?G.,@S MQE*&HO,;X_;[Y*^&3[C-CB]4W'-F=Y2Q]>D[+=F$Q(0!&-)<2BCID9I!)KOO MFG@O0]L0#M#J)M2_8VY:3:NY&+I7-+>IFT.`I3(*.I!`()(Q!E/'*&^ZTBJZ M@72I.DJECRDH'IY1!Q\@/TYG(7QX<8+GRFR+R$PGD&K4N;J,0^JU*KEY96%\ MO<[+'UMFJT<3;)./(FSH05SE-8X9S M\><5_>=K/T=&:A+V729]T-E^.W@G;?(QR?K_`!BYD$U?U)@$"D`H]VX[:G>]-R4NT;2;E5LO.)U`>%:> M)E^T,.<1^U4#MT<%,V])0&9)X`\@>43!/&?].3F_QU'6(C0^6/R@YT M\J/)^7BX"9M`<>8NZGI?&_!$"]WL:N MJ*4/*>(7GF?CA[=<,V8IRWS7\''.F:BR?>%%R=B:RQT=E[%B4LNXQYF:E.A; M2!&3UJV%*-GX"TUYR"\3+E3!TU7$BA13,DHF,XK;%M_U#VV'*32I;[?F!R4B ME6,APEB,1ARAH9J[C8:P4142VA6GYG/KZ<(GU>4+/5%Y3>!'DUR&QH\%[2,O M\4F%XKX*&(9TS2F)6MKNHA^!=BDDX=^15HY``#M71.'PUY@VY;ZNR;_I[=4@ M)K&7R"#^SI5)4L<"#,?6+*NM0AW;JWE$C4D8],Q\XUD>%I'+<'E.CK8#5MC/ M,\+V2VH+5-".K!T`.Y^]Y5O,*MDU"=IT@4,<#DV[@]BWHT@ MM1=K?)+29*5@#@)$YCD(J%E-14/M)IW3B)#$\9P]%=OIK_*71\%V'D%8J)C= MZZA8*0N]FQ1'Y&;3^9$8MJU6EYARLV+&+0=)4!//EG[+['+Q4&ZO%4K64ZDT75;0.3,;STVQCK1`6*,W(TD%DF#L7$> MLJ7WF;Q$BB9BF[P-)]X6&U[FVZ\VX@%3:-8-F/DLAVU%PI&R\FU]Q M-1W!U*+:N)9XF40]U-L".X"J&O(^S=NU&Y;]]N6`*5`*EGB4@R('23@.B9&4 M6U=;@NVT'G-`EU1$A[>V4:WWC#QDYG^:GE],0+:YN\C9:L#5W?,L9GRS+2+Z MOT2J)OB-#R3_`.51-1EPX_'IBLFVKIN2K*-92)\Y"'0^:OTMG+3BY@JU9PQ_EG'G):,Q]!. M[1?:#7:I.5&Z-8&';'?34O56,J\F6-G2AT$3KJM?<:NCH)F%,IS!VZA-D]+B8WJ=DN/5*ZAI M\APDG,_(1$8Y&X9D>-V=,T8'L,K$V>;PED&V8ZFY^#;N&T1.R5/DU8U](Q#= M^4CQ%B[,D)DBK`!P`!WU?-HOIO5F1=4<>< M24\-_2<JMM]M_3?5[^M__`.._^T/W MC$)V6`+BB0&*#^Z8GX>5BWRE"\:_.2VP:RC66B^,67"LG*(&]U%21J4A%F4( M)!`P&*F]-U#J&O,FSFVW-SV]IQ(4T7DX$3'#AE%EW1:DT+Q!(DF-2IQZS)-\ M=,U8DSS68JMV&QX9NU8R%7X&Z(+N:E)R]1?(R+!&=;-'+-TZ8B[;E,H0BJ9^ MFX&#UU[>OUN:NMJ>M3JE-LO@-E2<"E*@0=/`=T4I2O?EZ[\SI"EI7.7/H[8D M:?\`]=GD*$0/^R?B&7"2`,>7?$/OE?6W2J#P:*299#EAG$H_AO=Y*X?2/J+:-*1<&'``%ZTX\4(?N:U)"G%%M()`)3,N8 M@G$9<(G&\5+_`"=.$J4G#@2.`Y1''\:WEHS=XL'N7)/"%`P[<)7-*%/93\AE M)G8G#R/8TP\T9A'P"D%/PX)M'+F?.JY!0#[G3)MZ=+6WOL9C?#3!J:@LJIQG M/%4Y9D@DY?$Q&;%N%RVJ4$M:^F7S$.ERGU<7/.6CI&*>X2XE*M)-@[CG29XO M((@=J]04:N2B52ZJIGW05,':8HE-Z#N&^H13>A5B%0FJ155!((/^&,C//V,. MB-ZUM33K;6R0H@C$&^[W!$4HZ3B[Q% MSS4C015!5-LV70*5+[0F(0H;CTU;=UI$IV[4VX*"FQ3D27I)R.6>'SB)T"ZL M5_FALA2G,Y2,NL>_E&Z[B7I).+BY(H`'W@Q8/^@!U^;:HKAZ>OZ8:\#5B`R^ M6QD'"/<3](OED*+2%J_$4X]_WBHN&VD_;V/\E'[HA6X``"(@``(]1$``!$0#8-_R]-,^ M4*Y`171&8-$$&B".)_T1_@_LAK!R/4>Z-DYQ'Z^IR#_\@,YC^2^8.'_U3KO] MW5A^E"O*WM1KS\*_W%1&MQ_Z,[[%8)&A9&$B,>.><4U1SHKN MV*Y`"?-&!R(GQZ(VHO&^@^+KEEC"M9@X^X1X?9*HEIC6DBS?0.'L4.9&+%=` MISQ%CB0KYY""GH\P^TY:NB)*HG*("&P`(^*[S4[TL-P705SME+72*KRRV M"2I3BP``.!*L9^^?"6,)JQ5II@$K0UKX##Y1:WELJN&ZOX2^;9L#57'=4QI: M,`N;G7T<6P,!7J;,-;+*UB00L+!I6F;&+B*TVR#]^9GT1MC+A_P!4[-_V M=G/^BW>O%-)_QU/_`'T]XBYGOY#G]T]T:4]L.V2VO^=1K\=MO\>R_'X:^@-` M$IL8>,YMTVN7.2-,O]J<4A*=?+@7#WQ/X^JZXQ63*?!O!7)"JQ*\J;B_%6,^164 M,'\WJ%A&7K&?HBIHXLO^;:34+-6ZGDNJNI=N6KNYBV1<@A5F=TBYH"IN#'10 M%\T(FLNXJBRL7*Q./-BE'\5*"4J4#+&0(G*1X\Y8Q']JU5O;>+ M-:TG5E,X]XC8"APG\?HQ19O^J;Q#&&,@5T$N3"&'_NHS8Q>X'!9+\._)'0[> MO?W[;:\OF_;H"_*;JJ_S.0<FX6Q3,P+1W6C-U7]:-&-.WY/S"?R&<]#F]3@?TM0$G_V@_=B MC+TZK[JH2S5&UXX#?Z#G#C_ZM8%_]KZOKQ%N,2W#7`9?G'O]XJ+FMG^G,?Y* M/W1"M],V/"%L4W_.'\>L>+E&91768Q!H@CB8-RB`?F_LAK!R(Z#&4X&&;//3 MQMS=RQ\:>6L)\>J$_P`DY3L-NQ3(0M2CG\3&.7S6`O\`"R\JN#R;>Q\>FFRC MVQU3=RI1$"[!OJ:^GEPHK7NFFK;@XEFE0%34JJ;6XPRDJ< M5P';$;7P#^);R&<1_)5C_-O(CC;9,:8NAL79@K\C;I*QTB2;HRMDKB#2%9K, MX&R2;XQWCM,Q2G*D*91$`'8.NKA]5MW;:O6TTT5JK&7ZOSP=*=4Y3)GBD"(M MM:TW&BKDN532D("2)D8?A(YQ/:,F!R]I@W#;80'TV'UUYG2D)6EW'6E,O?+Z M18X,E'E$9'S2_3V0'D)N+ODQQQM=?Q-R>4BF,;;XNS,U4,;YA;0Z)T(MY.NX M=JO)5N[-68E;!*E1=IND$TTUTOL%4"UMB>J-;MAO[/5I<7:-4\,Y<0,UR>:,TOF'+N%EFK9(#%**KAQ'N4D$RB<2EW45.!>H@`;^NO+%$M!J M6'01Y04F9X"1$6*X"II:1BH@QJR&_@-\N1+TVES\-;B6/)D!K,FN-HQ/4FOWC'TCCZ\UR.LU6M%5/5;76YIHB]BYJ$E(D8R M8BY%HL"B+ALY;*G(G7;7CMBKJ*2H_-4Y4E]+LT$82,Y@SGESBU?)2Y M3I:<$_!(^Z("_D#^E-Y)8]M]EN/`B1A,V8>EGKZ3C<17"QQU4RK16JHF5)7F M$S-G;U:^1+,J@I-%3NF+\J92E435$.X?36V/6NGJF&6MRZ45S(`U$$MN`?M2 M'ARXB6.<0BZ;76I1=I,5='MW0U5&^&'S72I4L?)<4N1[2#$P-#1DO?HEA1RI MG-ML876025X6@#U,`)E)MZZF)W]L%P&IJG;:'@,FTF9_\M,1MNP[DJ/"^'$I MR[/;E#X?C#^EUY-4/-&+>0_+G+49@P,57"M9`K>.L'V%&R9'D)^NR",FR:3- M^:MTJY6(LRB8I.RL/O!9R@HHEWD*83#66]O5^AN5L79K*P32K!!*A+'+`8S$ MNJ)19=KO42]=2LDDSSGV1.UW$"A]G;<2[@'\WT`?3\FO/!)TE1S*AWB)P!(@ M#*-97SU\(/E1RUS/Y=Y,Q[Q#MMCHV1L_Y5MU,GF]MQT@C-UV>L,B[B9)-N]M MC9TW2>-U2J%(HF0Q>[J`:]A[9W[M.CV_1TU3<&$/MTX2I)*I@RR_#G%77:Q7 M!^X*=:964$Y\(V(?$>J3^,.)'&FB7MA^'+7C_CSB.K7"*>.6ION.?JV/:_%S M[%T];+*L3!&2#%8BBI%#)?8$P&$O77E2]U#-3?:IQA06EVJ=4@B9U!2U$$=8 M,631-K:H6DK$BEI(,^$@`9P@.P^?WQ&52P3E8F.9U'^]:[,2,#)`PKM]E602 M,0Y.R?`TE8RJNXV2;E*?PA*J]VE"BA=0V%#,8_2.,=Y_P#Q)R[:>>1?+JOOVE6ADK%8W#6CY.61 MA()>=A*PA*R9R4P0:,5K#9&#,IS[`9P[2('4P:W<],][M+;;H1D7JTJ07!4-^6,SC(<.7,P\GJ%PY0:((-$$&B"#1!!H@@T013 M;^WH@BO[OW>NB".I4W;V_G$?R_`HCOT]0#;KK13:G"-)D`<>GHC($P807DKR M(8*P+E];$?)I*S<<4I>2;,,89E6`^4+< MA9R)L,MXU@T01Q`!`?TMP^`;!T_>'U]-$$$8SROF3%N#:3,Y)S%D"H8QH%?;G^GJGA*:3?0>3,^.$7D#;,IQ"N[=]7*`Q521D:K29(G<1X M]<@G(R"(^VFF@D8YC^B_3WTG3:7D7;<:=;B@%I0<=&K'&?ZPGV<.<0+<6ZE% M"J:W&5UOEBLUO-5E<7 MI1Q*5MK;)ET!4P,Y3XF0LU&W6D6E='(>H;;S'D;GM])<4$?S5)'F]85E M/L'"&]ZUE`G1*+2CG+V^L)ALG+;ZE/A+WH9IX:X.Y]T2+$Y%,B\?#R$1:I!D MB;H^VT MK16L+0<<0"1/VZ84'!?5B>*Z3:D6D?ZR<&X]L#':.<.$D3$W]-UXJRNDCC^\ M.DCOHCO@XL"E4.A9^D*#N^QG%:U),^0^L>J9^J[\5\@!O:&S2E`H,:([""9U5@F+0_(D80#?9L(AUZ=-+:/T)W'4*\ MRXU+=.D&4D'S`1S)\,CT1P=WO;=/_IP5*Z?;YPU1R#^KEYLY`(YA./>'L)8$ M;/!.BSF9A65R]=DBK[)I'0+)EK]52>I&ZE`8YP7?^:;IJ=6ST.V^RL*KKEY[ MO_=A.B?:%DX9],I0RU&]+@[X*5HB?$#^W,0TQ)XU\P/EIN3&R6"D;=LUQHAZI,U$`D''K'OB93PSX$\4N!M`-C[C'AZOX\8NR-QL=D, MF:6OUU>H!_SA=+K(BO.V!P)@[BD45!LB(B"2:8?9"AKYN*\[B<#MW?6Z!/2D MGPIGF`.'?TQ-:*CIF$D-MI21+AC"R/92[>SVR=O][VAV^N_IZ;;Z82E)`21@ M/[(<>,^,=FMH(-$$4$=@WVW_`'?VM842!X1,P1Y5WB#8`,NHFBF(@7W%E2)$ M`1$"E`3'$"@)C"`!UZCK9*5.%24":TC(<8V(0E)4M0`$<%WZ+8""L=),RIP3 M2(HX13%90PF!--(3G`IU%.T=B@/=^;6H*L-0./;+G[HU04*$U*`!RZ8[TUO< M`1`OV=BB4P&W`Y3!N`@.P=-OCZ:Y>:0MQLB11+CG/NC&,\!,1V=_4`V]?0=_ MR>OP^&NIUS,A@)9&:&B\B4&E7V+42,F=C]6\"OB(J1TU(_@YB:04 M2$#)GLRELM(%'M`/\'/6-^B(=/02B&^DSWJ3OY\Z57%[RO\`F_)(@&W[2HAQ M3(G+*9E\(6AC+@OPSPR"/[*N*W'RAK-S$,@^KV):2SE4S)E[2G+*?XKS7*G45E07>A<8$SE.(!]GKMJ<>E[E-3;L957I\QK\NX5#I\M4A[ MX:[RTXY2$,GQ:@>>4^''I!AF'*'+#+'OX M]>?D)F6!B[9@#CM6JXQ;F M0"-C(V8BWDK)MG#1W*&B6IP2V5`.[-P],K5;WRQ6U*V2Y=4-M!X\W$H*121T]C*""I--N\=CT%EHQ M74:W5M>9+5@I"L<"%IFF1S$S,Y$`X1VI+FMY_P`IS!SE*1'6,^OEGE'W?J6E MF!.!.(T9B+LE@@'W.GBK&V:K5!21+9;A67UEFT9^HPJ$2^C7[Z2L<8*C5!NF MX1,LJH4H&`VPZX^FNM6XBTPI"7E4;TBN6D'1,%4Y`##,X0HO()H9S($\99F8 M(Z>L=(AH2IQO'@WE"\>>+/&YP_Y=\"LY1^3G^2,Z*\D).X8CK^1^+4/'*CD. ML)4C(=_NILE/)))`/8(P+[K;M/W%W$#(SUS[DC;%RK-S5%%6T@8"$?ERV[H6 M5I"9K:P3B1F`1ACS:_)936L?E/-0N7ZP(P'6.L<_J6LS5[*^?);$- M$XVN<.8`R_*XQC\-7A7.3WE'GQC1YX:]?+/09*FU*0Q/5>]V18\8QE70+G3; MC[@[FTUT'IC0_DZ1%S=6+C6,%8*2D(0=,P#/$SX8D3G.0E'2HO+Z:T--H5Y0 M5(F1D.L\.F+QR+Y$8'C!Y`_(OSS/6K%:JPW\6?!G(5$QI)/G,(N_LN7+*5"E MPTVDLD=*O*JOI]`LDX!$%$6Z2O03`4HAVL]I>I6K@Q74]('"IY&EM1D2I(F M`H9<99S$Y0X_>)G`!6,I"<_I'IQ=Y[>65NYR1?'R]XAXPXB@9/DU)8-=D3;&*RL?4'JA@N8*0`@8R"M1F<1I&D&9S M`$D_+NB5%QXS/"\B,'8@SK78N4@H3+V.*AD2-@YQ%1M-P MK>V0C:7"'EFZB+0F>"E"0' MC#:>,D[?Y;&45:;1CFT+VZ$@V-BD6JF.[U!W=NQ2BY)VR:*)RJ\(5NH<5`,F M4_<4!$`#3E8KPNRW1-:VV%Z6E9Y&8E\)SA,^G4F73]839S5\0N$^9W(OASRI ME+7*XSS/Q%OM*LS6T5NOQ,HIE"GTNR15LCL?7`D@LV,W:-YJ,.HS?)&4<,RO M'!"E,4^P.]DWO%R7G,YV MY_'G$Q%>@(&R^S?7F9X*KR$?/U5#(]JL#K[W/)1MH9JOEW1"+'=F=*)F*4NV MW*W>H5\M]#=J%MEF=Q"D:E%1T:DE,TR5A(<\9YDPLD8XS^9B MS<(>"G%G'C'_`#XJ6(.1.8L96GF_D=M?8S*>,@:T6]L*E@9UE9L]>,4V[&<44]I5XUVFW5EO+0=HJUI(()(DH*!20!C,'JYSP@J*(.5#3H7BG^ MWY?*&_[CX,%@N_(+^K]SUY*<8./O*J_RF3L;1-%?,'MKLZQ'%S>8WR/, MQYKCBPMM4[P=?=XF/V'[0-L4G;(Z3?U2W2L(K*%EVLIFRAMPK6"`1+(+TG#H MZI0A;O]XN\WCSD?Q(PEQ*=T`P M)EEJ/$X$>MY"D9$AL@.GCR:E;HA(,6[@5'2&PK)"8YE`4,&F^FWUL],XH*4H:M*1SR`[.$6=C'PRVUD[: MH\D?(ARBY-U2I80R7@C%U,E&%-Q="U"OY0I\A0IFRV8:.V(XRC$E*D)S.0PQ(D<8YHLK# M9U)69RD,L/[/T0FG$7T_60Z6/%*HWKG<2SX8X79;I.4<.8ZIO%/$V.96P+4N M4<.V2&4\@00%0Q=D3%-,F7%.C)DPD`B+=$YFFR>P`!> MUO3O^ULTCAH;;^7O#U.I!2EQ?DR(()TZB)Y8'JG*.B;4M1FZ[X/T2X\_[(R# MDGPD/WN6.1UUXW<\^1?$G'7,"R/+GR,P]C6OT*Q0]CN$W^KM5FQ_:;2P=3^* MYBSMCJ%77C_<53$X>V8"D*0$=O\`4&H-MIZ6XV^GJ:AALI0ZIQP*2)JPDEP` MYDX@XXYQL;*C7J:=TM\0)8GX?7I,/0XFQE7L.XWH.+*HM+N:WCJI0-.@W5BE MWT_/NX^OQJ,8V>SFP!"':MVKJ''5IT!2B9# =+$Y<
-----END PRIVACY-ENHANCED MESSAGE-----